Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

Outdoor Channel Holdings Inc. (OUTD) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Outdoor Channel Holdings is an entertainment and media company operating in three business segments: The Outdoor Channel (TOC), Production Services, and Aerial Cameras. The Outdoor Channel is a national television network that provides traditional outdoor related lifestyle programming and outdoorchannel.com. … Continue reading

Posted in Noble Equity Conference | Leave a comment

Computer Task Group Inc. (CTGX) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Computer Task Group develops IT solutions for companies in several higher-growth industries including healthcare, energy, and technology services. CTG offers hospitals, physician groups, and regional health information exchanges a full range of electronic medical record services.  Additionally, CTGX has developed … Continue reading

Posted in Noble Equity Conference | Leave a comment

Amtech Systems Inc. (ASYS) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Amtech Systems is a global provider of thermal processing systems and microelectromechanical systems (MEMS) industries. It sells these products to manufacturers of solar cells, silicon wafers, and semi-conductors worldwide. ASYS also offers plasma-enhanced chemical vapor deposition (PECVD) and phosphorus silicate … Continue reading

Posted in Noble Equity Conference | Leave a comment

Implant Sciences Corp. (IMSC) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Implant Sciences engages in the development, manufacture, and sale of sensors and systems for use in security, safety, and defense industries primarily in the United States, China, and Iraq. Its products include Quantum Sniffer, a QS-H150 portable explosives detector for … Continue reading

Posted in Noble Equity Conference | Leave a comment

MetaStat, Inc. (MTST) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

MetaStat is a life science company operating through its subsidiary MetaStat BioMedical to develop and commercialize proprietary clinical diagnostic tests that predict the probability of blood borne systemic metastasis of cancer; and therapeutics to prevent systemic metastasis. Its products include … Continue reading

Posted in Noble Equity Conference | Leave a comment

Bion Environmental Technologies Inc. (BNET) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Bion Environmental Technologies provides an environmental solution to a source of pollution in United State agriculture, Confined Animal Feeding Operations (CAFOs). The company is pursuing business opportunities in retrofit and environmental remediation of existing CAFOs to reduce nutrient releases, gaseous … Continue reading

Posted in Noble Equity Conference | Leave a comment

CNS Response Inc. (CNSO) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

CNS Response operates as an online neuroinformatic company. The company’s primary business is Neurometric Information Services, operated by CNS California, which is focused on neurometric analysis, research, development, and commercialization of a patented system that provides data to psychiatrists and … Continue reading

Posted in Noble Equity Conference | Leave a comment

ZAGG Inc. (ZAGG) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

ZAGG designs, manufactures, and distributes protective coverings, audio accessories, and power solutions for consumer electronic and hand-held devices under the brand names invisibleSHIELD, ZAGGskins, ZAGGbuds, ZAGGsparq, ZAGGmate, ZAGGfolio, ZAGGkeys, iFrogz, and Earpollution. The company operates in three segments: ZAGG segment, … Continue reading

Posted in Noble Equity Conference | Leave a comment

Coronado Biosciences Inc. (CNDO) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

Coronado Biosciences is focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The company’s two principal pharmaceutical product candidates in clinical development include or CNDO-201 (TSO) for the treatment of autoimmune diseases, … Continue reading

Posted in Noble Equity Conference | Leave a comment

DARA BioSciences, Inc. (DARA) Starts Presentation at Noble Financial’s 9th Annual Equity Conference

DARA BioSciences is a specialty pharmaceutical company engaged in developing and commercializing oncology treatment and supportive care products. Through agreements with various entities, the company has comprehensive commercial coverage across the national oncology market. DARA is part of an integrated … Continue reading

Posted in Noble Equity Conference | Leave a comment